These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17659494)

  • 21. Unraveling the links between diabetes, obesity, and cardiovascular disease.
    Huang PL
    Circ Res; 2005 Jun; 96(11):1129-31. PubMed ID: 15947251
    [No Abstract]   [Full Text] [Related]  

  • 22. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vascular reactivity and glucidic disorders].
    Boulanger C
    Therapie; 1997; 52(5):385-6. PubMed ID: 9501561
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
    Iwakiri Y
    J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
    Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
    Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
    Wang S; Peng Q; Zhang J; Liu L
    Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal microangiopathy in diabetes.
    Striker LJ
    Therapie; 1997; 52(5):457-8. PubMed ID: 9501575
    [No Abstract]   [Full Text] [Related]  

  • 34. The pathogenesis of the diabetic kidney and the role of insulin-like growth factor.
    Cohen SE; Popovtzer MM
    Int J Artif Organs; 1997 May; 20(5):244-50. PubMed ID: 9209923
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal hypertrophy in experimental diabetes.
    Flyvbjerg A; Mogensen CE; Osterby R; Orskov H
    J Diabet Complications; 1991; 5(2-3):62-4. PubMed ID: 1770054
    [No Abstract]   [Full Text] [Related]  

  • 36. Moving closer to an understanding of the hyperfiltration of type 2 diabetes mellitus.
    Wesson DE
    Am J Physiol Regul Integr Comp Physiol; 2006 Apr; 290(4):R973-4. PubMed ID: 16537822
    [No Abstract]   [Full Text] [Related]  

  • 37. Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.
    Nakagawa T; Sato W; Kosugi T; Johnson RJ
    J Diabetes Res; 2013; 2013():184539. PubMed ID: 24386643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of nitric oxide in murine cardiovascular development.
    Nath AK; Madri JA
    Dev Biol; 2006 Apr; 292(1):25-33. PubMed ID: 16442519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of early postnatal hyperglycaemia on renal cortex maturity, endothelial nitric oxide synthase expression and nephron deficit in mice.
    Cunha AR; Aguila MB; Mandarim-de-Lacerda CA
    Int J Exp Pathol; 2008 Aug; 89(4):284-91. PubMed ID: 18715472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide in diabetic nephropathy.
    Craven PA; DeRubertis FR; Melhem M
    Kidney Int Suppl; 1997 Sep; 60():S46-53. PubMed ID: 9285902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.